A detailed history of Exane Derivatives transactions in Henry Schein Inc stock. As of the latest transaction made, Exane Derivatives holds 1 shares of HSIC stock, worth $69. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 4,654 99.98%
Holding current value
$69
Previous $405,000 100.0%
% of portfolio
0.0%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$73.17 - $91.96 $340,460 - $427,889
-4,653 Reduced 99.98%
1 $0
Q1 2022

Apr 22, 2022

BUY
$72.72 - $88.73 $335,093 - $408,867
4,608 Added 10017.39%
4,654 $405,000
Q4 2021

Jan 28, 2022

SELL
$70.34 - $80.1 $366,823 - $417,721
-5,215 Reduced 99.13%
46 $3,000
Q3 2021

Oct 26, 2021

BUY
$73.8 - $81.23 $388,261 - $427,351
5,261 New
5,261 $400,000

Others Institutions Holding HSIC

About HENRY SCHEIN INC


  • Ticker HSIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 136,115,008
  • Market Cap $9.45B
  • Description
  • Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution s...
More about HSIC
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.